RYBELSUS® 14 mg contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of adults with type 2 diabetes mellitus. It is the first GLP-1 receptor agonist available in an oral tablet formulation and is used alongside diet and exercise to improve glycemic control.

Composition

• Active ingredient: Semaglutide
• Strength: 14 mg per tablet
• Dosage form: Tablets
• Route of administration: Oral

Package Contents

• 1 box containing 30 tablets
• Patient information leaflet

Indications

RYBELSUS is indicated for:

• Improving blood glucose control in adults with type 2 diabetes mellitus
• Use in combination with diet and exercise
• Use alone or with other antidiabetic medications when appropriate

Key Features

• Oral GLP-1 receptor agonist therapy
• Once-daily dosing
• Helps improve glycemic control
• May support weight reduction in some patients as part of diabetes management
• Convenient tablet formulation without injections

Administration

• Take once daily as prescribed by a healthcare professional
• Swallow whole with a small amount of water
• Take on an empty stomach and wait at least 30 minutes before eating, drinking, or taking other oral medications

Storage

• Store at room temperature according to product labeling
• Keep in the original package to protect from moisture
• Keep out of reach of children

Packaging

• Product: RYBELSUS®
• Active Substance: Semaglutide
• Strength: 14 mg
• Dosage Form: Tablets
• Pack Size: 30 tablets

Note: RYBELSUS is a prescription medication and should be used only under the supervision of a qualified healthcare professional. Patients should follow the prescribed dosing schedule and lifestyle recommendations to achieve optimal treatment outcomes.